What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?

Epilepsy and Behavior

Volumn 20, Issue 3, 2011, Pages 528-532

  Kwon, Oh Young ^a   Park, Sung Pa ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Adverse event; Antiepileptic drugs; Depression; Monotherapy; Quality of life; Well controlled epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; ADVERSE EVENT PROFILE; AGED; ARTICLE; BECK DEPRESSION INVENTORY; DEMOGRAPHY; DEPRESSION; EDUCATIONAL STATUS; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; QUALITY OF LIFE; QUALITY OF LIFE IN EPILEPSY INVENTORY 31; QUESTIONNAIRE; SCORING SYSTEM; SEIZURE; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; EPILEPSY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 79952739430     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.01.010     Document Type: Article

References (38)

1. Jacoby A., Snape D., Baker G.A. Determinants of quality of life in people with epilepsy. Neurol Clin 2009, 27:843-863.
2. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45:544-550.
3. Park S.P., Song H.S., Hwang Y.H., Lee H.W., Suh C.K., Kwon S.H. Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy. Epilepsy Behav 2010, 18:455-459.
4. Tracy J.I., Dechant V., Sperling M.R., Cho R., Glosser D. The association of mood with quality of life ratings in epilepsy. Neurology 2007, 68:1101-1107.
5. Canuet L., Ishii R., Iwase M., et al. Factors associated with impaired quality of life in younger and older adults with epilepsy. Epilepsy Res 2009, 83:58-65.
6. Kwan P., Yu E., Leung H., Leon T., Mychaskiw M.A. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia 2009, 50:1059-1066.
7. Gilliam F.G., Fessler A.J., Baker G., Vahle V., Carter J., Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004, 62:23-27.
8. Perucca P., Carter J., Vahle V., Gilliam F.G. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009, 72:1223-1229.
9. Jacoby A., Johnson A., Chadwick D. Psychosocial outcomes of antiepileptic drug discontinuation. Epilepsia 1992, 33:1123-1131. for the Medical Research Council Antiepileptic Drug Withdrawal Study Group.
10. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993, 34:1007-1016.
11. Kwan P., Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 2004, 75:1376-1381.
12. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
13. Jacoby A. Epilepsy and the quality of everyday life. Findings from a study of people with well-controlled epilepsy. Soc Sci Med 1992, 34:657-666.
14. Auriel E., Landov H., Blatt I., et al. Quality of life in seizure-free patients with epilepsy on monotherapy. Epilepsy Behav 2009, 14:130-133.
15. Commission on Classification and Terminology of the International League against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
16. Commission on Classification and Terminology of the International League against Epilepsy Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985, 26:268-278.
17. American Psychiatric Association DSM-IV sourcebook 1994, vol. 1. American Psychiatric Assoc., Washington, DC.
18. Kim Z.S., Lee Y.S., Lee M.S. Two- and four-subset short forms of the Korean Wechsler Adult Intelligence Scale. Seoul J Psychiatry 1994, 19:121-126.
19. Rhee M.K., Lee Y.H., Jung H.Y., et al. A standardization study of Beck Depression Inventory: II. Korean version (K-BDI): validity. Kor J Psychopathol 1995, 4:96-104.
20. Yoo H.J., Lee S.A., Heo K., et al. The reliability and validity of Korean QOLIE-31 in patients with epilepsy. J Korean Epilepsy Soc 2002, 6:45-52.
21. Baker G.A., Frances P., Middleton E. Initial development, reliability, and validity of a patient-based adverse events scale. Epilepsia 1994, 35:80.
22. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
23. Lambert M.V., Robertson M.M. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999, 40(Suppl. 10):21-47.
24. Hermann B.P., Seidenberg M., Bell B. Psychiatric co-morbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000, 41(Suppl. 2):31-41.
25. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
26. Jacoby A., Baker G.A., Steen N., Potts P., Chadwick D.W. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996, 37:148-161.
27. Mendez M.F., Cummings J.L., Benson D.F. Depression in epilepsy: significance and phenomenology. Arch Neurol 1986, 43:766-770.
28. Indaco A., Carrieri P.B., Nappi C., Gentile S., Striano S. Interictal depression in epilepsy. Epilepsy Res 1992, 12:45-50.
29. Edeh J., Toone B. Relationship between interictal psychopathology and the type of epilepsy: results of a survey in general practice. Br J Psychiatry 1987, 151:95-101.
30. Robertson M.M., Trimble M.R. Depressive illness in patients with epilepsy: a review. Epilepsia 1983, 24(Suppl. 2):109-116.
31. O'Donoghue M.F., Goodridge D.M., Redhead K., Sander J.W., Duncan J.S. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999, 49:211-214.
32. Baker G.A., Jacoby A., Chadwick D.W. The associations of psychopathology in epilepsy: a community study. Epilepsy Res 1996, 25:29-39.
33. Ettinger A., Reed M., Cramer J. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 2004, 63:1008-1014. for the Epilepsy Impact Project Group.
34. Cramer J.A., Blum D., Fanning K., Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004, 5:337-342. for the Epilepsy Impact Project Group.
35. Panelli R.J., Kilpatrick C., Moore S.M., Matkovic Z., D'Souza W.J., O'Brien T.J. The Liverpool Adverse Events Profile: relation to AED use and mood. Epilepsia 2007, 48:456-463.
36. Canevini M.P., De Sarro G., Galimberti C.A., et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010, 51:797-804.
37. Baker G.A. Assessment of quality of life in people with epilepsy: some practical implications. Epilepsia 2001, 42(Suppl. 3):66-69.
38. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., Meador K.J. Clinical assessment of axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 2005, 17:172-179.